 |
Priligy 30mg |
3 Tablets |
92 € |
 |
|
Priligy 30mg |
6 Tablets |
132 € |
|
|
Priligy 30mg |
9 Tablets |
182 € |
|
|
Priligy 30mg |
12 Tablets |
222 € |
|
|
Priligy 60mg |
3 Tablets |
102 € |
|
|
Priligy 60mg |
6 Tablets |
156 € |
|
|
Priligy 60mg |
9 Tablets |
216 € |
|
|
Priligy 60mg |
12 Tablets |
266 € |
|
Priligy
Dapoxetine is a drug specifically developed for the on-demand treatment of PE [Premature Ejaculation] and is the first oral medication (tablet) to be approved for this condition.
Dapoxetine has been extensively evaluated in five randomised, placebo-controlled Phase III clinical trials involving more than 6,000 men with PE and their partners. This is the largest and most comprehensive clinical trial programme to date for a drug therapy to treat PE. Dapoxetine is a unique, short-acting, selective serotonin reuptake inhibitor (SSRI) designed to be taken only when needed, that is 1–3 hours before sexual intercourse is anticipated, rather than every day.
“Dapoxetine is an important new medication for doctors and patients," commented Professor Dr Hartmut Porst, Private Institute for Urology and Andrology, Hamburg, Germany.
“The lack of a previously approved oral medication for PE has contributed to a substantial deficiency in the diagnosis and treatment of this common condition. For the first time, physicians will be able to provide men with a pharmaceutical product that has been specifically developed for PE and that is proven to be effective.”
Premature Ejaculation
PE is a distressing sexual dysfunction that can be present from the first sexual encounter or can develop later in life. Depending on the methodology and criteria used to evaluate the prevalence of PE in studies, the reported proportion of men affected with this condition at some point in their lives has ranged from 4–30%.
Experts in PE from the International Society of Sexual Medicine (ISSM) define the condition as consisting of three major components: a short time to ejaculation, lack of ejaculatory control and negative personal impact or distress related to ejaculation. The condition is defined by the ISSM as “a male sexual dysfunction characterised by ejaculation which always or nearly always occurs prior to or within about one minute of vaginal penetration; and inability to delay ejaculation on all or nearly all vaginal penetrations; and negative personal consequences, such as distress, bother, frustration and/or the avoidance of sexual intimacy”. Unlike erectile dysfunction (ED), which tends to affect older men, PE has similar prevalence across all age groups. In fact, more men are believed to experience PE than ED.
A combination of physiological and psychological factors are believed to influence the mechanism of ejaculation 8, 9. Men with PE appear to go through the same process of ejaculation as other men, but it happens more quickly and with a reduced feeling of control. Research suggests serotonin plays a central role in the timing of ejaculation.
Priligy™ (dapoxetine) receives first regulatory approvals for the treatment of premature ejaculation (PE)
Please note that when requesting prescription medications through this website it is not possible to replace a full medical consultation and physical examination with you own doctor.
